| Bexarotene studied in …STUDIED_INderived27 of 27show fewer |
|---|
| → studied in | NCT00238628Phase 1/Phase 2 · completed A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer · 27 trials list this drug (1 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296304Phase 1 · recruiting A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides · 27 trials list this drug (1 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04664829Phase 1 · completed The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC · 27 trials list this drug (1 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116622Phase 1 · completed Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract · 27 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323658Phase 1 · completed Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer · 27 trials list this drug (1 active) | — | — | Breast Atypical Lobular Hyperplasia,Breast Lobular Carcinoma In Situ,Breast Atypical Ductal Hyperplasia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578499Phase 3 · completed A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) · 27 trials list this drug (1 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615784Phase 2 · terminated Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia · 27 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00411632Phase 2 · completed BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) · 27 trials list this drug (1 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · 27 trials list this drug (1 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01007448Phase 4 · completed Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) · 27 trials list this drug (1 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00153842Phase 1/Phase 2 · terminated A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer · 27 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425477Phase 2 · completed Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · 27 trials list this drug (1 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255801Phase 2 · completed Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma · 27 trials list this drug (1 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056056Phase 3 · terminated Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides · 27 trials list this drug (1 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00316030Phase 1 · completed Study of Bexarotene in Patients With Acute Myeloid Leukemia · 27 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660231Phase 2 · completed Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma · 27 trials list this drug (1 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01001143Phase 1 · completed Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) · 27 trials list this drug (1 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718770early Phase 1 · completed A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression · 27 trials list this drug (1 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514293Phase 2 · unknown Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 27 trials list this drug (1 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030589Phase 2 · unknown Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma · 27 trials list this drug (1 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003752Phase 2 · completed Bexarotene in Treating Patients With Metastatic Breast Cancer · 27 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050973Phase 3 · completed Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer · 27 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322296Phase 2 · terminated Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis · 27 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030849Phase 2 · completed Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma · 27 trials list this drug (1 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055991Phase 1 · completed Bexarotene in Preventing Breast Cancer in Women at Genetic Risk · 27 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00306969Phase 1/Phase 2 · completed Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma · 27 trials list this drug (1 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002212Phase 2 · completed A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma · 27 trials list this drug (1 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |